Collection: Safety Shield Studies
Safety Shield uses AI to streamline pharmacovigilance, reducing specialist workload by 80% while improving article selection accuracy by 37%. It ensures faster, more reliable safety signal detection without sacrificing oversight, helping manage the overwhelming flow of data to protect patient safety.
-
Safety Shield Study for CEMIPLIMAB
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for CEPHALEXIN
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for CERTOLIZUMAB PEGOL
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for CETIRIZINE
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for CHLOROQUINE
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for CICLOPIROX
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for CIDOFOVIR
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for CIPROFLOXACIN
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for CLARITHROMYCIN
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for CLASCOTERONE
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for CLIMBAZOLE
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for CLINDAMYCIN
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for CLOBETASOL
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for CLOTRIMAZOLE
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for COAL TAR
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for COBIMETINIB
Regular price From €800,00 EURRegular priceUnit price / per
Explore our exclusive study series
-
Safety Shield Studies
Safety Shield uses AI to streamline pharmacovigilance, reducing specialist workload by 80%...
-
Expert Mapping Studies
Expert Mapping Reports cut screening time by 10 days and reduce failed...
-
Clinical Endpoints Studies
This targeted analysis delivers a robust assessment of clinical endpoints tailored to...